AbbVie
The Associate Director, Field Care Model Operations is a field-based execution role within the Patient Services Botox franchise team, responsible for ensuring the successful rollout of Botox Complete and building organizational readiness for IRA/Medicare policy changes. This operational and enablement role focuses on solving real-world field problems, providing technical triage, care model support, and field training to Field Reimbursement Managers and regional teams. The role involves translating policy changes into actionable field readiness and equipping customers with the necessary knowledge and tools.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a global, research-driven biopharmaceutical company that was spun off from Abbott Laboratories in 2013. It develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology — with Humira historically its flagship product — and has broadened its portfolio through acquisitions (notably Allergan) and strategic collaborations. AbbVie emphasizes a robust R&D pipeline, targeted therapies, and global commercial and manufacturing capabilities. The company focuses on delivering long-term treatment options for complex, chronic and serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.
Director, Government Affairs - U.S. Reimbursement
AbbVie
Director, Government Affairs - U.S. Reimbursement
AbbVie
Director, Government Affairs - U.S. Reimbursement
AbbVie
Field Reimbursement Manager, Minneapolis
CSL
Health Care Regulatory Associate General Counsel
8A7883D080D90BE90180DD1B6D6300D7
Director, National Field Access
Corcept Therapeutics